Prakiraan wutah bathi saben saham kanggo taun ngarep: Quest Diagnostics (DGX)

Quest Corp (DGX) - logo korporat

The projected net profit trend formed by GURU.Markets quotes indicates Medicare risks and cyber threats, while the value of 6.10 shows the latest figure. Stable demand offset losses from PCR tests despite wage inflation. The diagnostic efficiency of Quest Diagnostics (DGX) relies on costly temperature-controlled sample logistics, which are critical for the accuracy of results.

DGX: Prakiraan wutah bathi resik saben saham ing taun ngarep Quest 04.07.2022 - 12.11.2026

Rincian metrik keuangan lan pasar questdiagnostics.com (DGX)

- rega lan prakiraan konsensus rega:
- indikator kapitalisasi bursa perusahaan:
Pambiji fundamental perusahaan:Quest, DGX
Produk merek Quest Diagnostics Inc.

Quest Diagnostics operates an isolated network of laboratories exposed only to the risks of supply chain disruptions for Asian reagents. This indicator captures the real-time adjustment of market expectations for future earnings. By analyzing the consensus EPS forecast for the coming year, an investor can see the immediate market reaction of analyst models to corporate events. An increase in this metric signals optimism, but simultaneously narrows the company's financial margin of safety.

Perusahaan pesaing

Prakiraan wutah bathi resik saben saham kanggo taun ngarep Agilent Tech|ILMN - Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep|Prakiraan wutah bathi saben saham kanggo taun ngarep EXAS (Exact Sciences)|Prakiraan wutah bathi kanggo taun ngarep revvity.com (RVTY)|Prakiraan wutah bathi kanggo taun ngarep BIO (Bio-Rad)|Anbio Biotechnology Ltd (NNNN) - Prakiraan wutah bathi resik saben saham ing taun ngarep|SHC - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep QuidelOrtho Inc. QDEL|OPK (OPKO Health, Inc.) - Prakiraan wutah bathi saben saham kanggo taun ngarep|CDNA: Proyeksi tambahing bathi saben saham ing taun ngarep|Prakiraan wutah bathi saben saham kanggo taun ngarep MRVI|FLGT: Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep LAB|Cytek Corp - Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep OSUR (OraSure Technologies)|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Exagen Inc (XGN)|MDxHealth - Prakiraan wutah bathi kanggo taun ngarep|LUCD - Prakiraan wutah bathi kanggo taun ngarep|PRE: Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep Insight Molecular Diagnostics Inc IMDX|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Trinity Biotech PLC|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep PRPH (prophaselabs.com)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Ainos (AIMD)|CODX - Prakiraan wutah bathi resik saben saham ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Heart Test Laboratories Inc. HSCS|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Biomerica Inc (BMRA)|CDIO: Prakiraan wutah bathi saben saham kanggo taun ngarep|onconetix.gcs-web.com - Proyeksi tambahing bathi saben saham ing taun ngarep|VRAX: Prakiraan wutah bathi kanggo taun ngarep|BJDX - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|AWH (Vermillion) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi saben saham kanggo taun ngarep Accelerate Diagnostics Inc (AXDX)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Centogene NV (CNTG)|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep enzo.com|Prakiraan wutah bathi kanggo taun ngarep FRES (Fresh2 Group)|GENE: Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep|23andMe Inc. - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep Psychemedics Inc (PMD)